Stem Cell Exosome Therapeutic Market Size, Share, Growth, and Industry Analysis, By Type (Mesenchymal Stem Cell{MSC}, Dendritic Cells, Umbilical MSC & others), By Application ( Precision Medicine, Regenerative Medicine & Others) and Regional Insights and forecast to 2032

Updated On: 10 June 2024

STEM CELL EXOSOME THERAPEUTIC MARKET REPORT OVERVIEW

• 

• to learn more about this report

The global stem cell exosome therapeutic market size was USD 153 million in 2022 and will touch USD 410.5 million by 2029, exhibiting a CAGR of 15.6% during the forecast period.

The stem cell exosome therapeutic are a particular class of cell-derived extracellular vesicles composed of endosomes that are normally 30-150 nm in diameter. The global stem cell exosome therapeutic are gaining popularity rapidly as a way to obtain the therapeutic benefits of stem cells without the complications and difficulties in delivering cells to patients. Stem cell exosome therapeutic are sold as a diagnostic devices, therapeutic agents, cosmeceuticals, research tools and much more. The increasing pervasiveness of auto-immune disease, chronic degenerative inflammation, lyme disease, and other chronic degenerative disease has boosted the demand for stem cell exosome therapeutic market. The emerging research activities in stem cell exosome therapeutic market will accelerate the market growth in upcoming years. In the last few years, the technologies related to stem cell exosomes therapeutic have been mainly developed and have become very useful for precision medicine, liquid biopsy and regenerative medicine. Hence, advancements in exosome isolation and purification techniques and rising healthcare infrastructure has given lucrative growth opportunities to the global stem cell exosome therapeutic market.

COVID-19 Impact: Unprecedented Surge in Market Growth due to positive involvement of Stem Cell Exosome Therapeutic in cell communication

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic positively impacted the stem cell exosome therapeutic market.  Due to pandemic there was an unprecedented surge in stem cell exosome therapeutic market’s research theory in order to understand the virus. Stem cell exosome therapeutic are small vesicles that were studied to better understand the virus’s mechanism of infection and its effect on host cells. This led to increase in demand for stem cell exosome therapeutic related research tools and diagnostics for studying COVID-19. Stem cell exosome therapeutic played an important role in some vaccine development process. For example, researchers investigated exosome- based vaccine platforms for the presentation of viral antigens to the immune system. This research increased interest in exosome-related technologies. Researchers had also investigated the use of exosomes in COVID-19 diagnostics which included the development of diagnostic assays that detect viral RNA or proteins within exosomes present in patient samples. These efforts contributed to the growth of the stem sell exosome therapeutic diagnostic sector. Hence, COVID-19 pandemic had a significant effect on the stem sell exosome therapeutic market.

LATEST TRENDS

"Demand for Precision Medicine gave a boost to Market Growth"

A latest trend in the global stem cell exosome therapeutic market is that there is a rise in demand for precision medicine which presents a significant opportunity for exosome research due to the unique characteristics of exosomes and their potential applications in providing medical treatments to individual patients. Stem cell exosome therapeutic are implicated in the development of drug resistance in various diseases. Studying the content and function of stem cell exosomes therapeutic sheds by resistant cells can contribute to the identification of mechanism underlying resistance.

STEM CELL EXOSOME THERAPEUTIC  MARKET SEGMENTATION

• 

• to learn more about this report

By Type

Based on type the global market can be categorized into Mesenchymal Stem cell, Dendritic Cell, Umbilical MSC & others.

• Mesenchymal Stem cell: Mesenchymal stem cells (MSCs) are also known as mesenchymal stromal cells or medicinal signaling cells. Mesenchymal stem cells (MSCs) have the ability to self-renew and also exhibit multilineage differentiation. MSCs can be isolated from a variety of tissues, such as umbilical cord, endometrial polyps, menses blood, bone marrow, adipose tissue, etc. This is because the ease of harvest and quantity obtained make these sources most practical for experimental and possible clinical applications.

• Dendritic Cell: It is a special type of immune cell that is found in tissues, such as the skin, and boosts immune responses by showing antigens on its surface to other cells of the immune system. A dendritic cell is a type of phagocyte and a type of antigen-presenting cell (APC). Dendritic cells are present in tissues that are in contact with the body's external environment, such as the skin and the inner lining of the nose, lungs, stomach and intestines. They can also be found in an immature and mature state in the blood. Once activated, they migrate to the lymph nodes, where they interact with T cells and B cells to initiate and shape the adaptive immune response.

• Umbilical MSC: Umbilical MSC  are a class of multifunctional stem cells isolated and cultured from umbilical cord. They possess the characteristics of highly self-renewal, multi-directional differentiation potential and low immunogenicity. Their application in the field of tissue engineering and gene therapy has achieved a series of results. The ability of Umbilical MSC to support hematopoietic microenvironment and suppress immune system suggests that they can improve engraftment after hematopoietic stem cell transplantation, which shows great potential in treatment of hematologic diseases.

By Application

Based on application the global market can be categorized into Precision Medicine, Regenerative Medicine and others.

• Precision Medicine: It is a form of medicine that uses information about a person’s own genes or proteins to prevent, diagnose, or treat disease. In cancer, precision medicine uses specific information about a person’s tumour to help in making a diagnosis, plan treatment, find out how well treatment is working, or make a prognostic. Due to these characteristics it is also called as personalized medicine. Examples of precision medicine are targeted therapies to treat specific types of cancer cells, such as HER2-positive breast cancer cells, or using tumour marker testing to help diagnose cancer.

• Regenerative Medicine:  Regenerative medicine is a field that brings together experts in biology, chemistry, computer science, engineering, genetics, medicine, robotics, and other fields to find solutions to some of the most challenging medical problems faced by humankind. Regenerative medicine seeks to replace tissue or organs that have been damaged by age, disease, trauma, or congenital issues, vs. the current clinical strategy that focuses primarily on treating the symptoms. The tools used to realize these outcomes are tissue engineering, cellular therapies, and medical devices and artificial organs. Combinations of these approaches can amplify our natural healing process in the places it is needed most, or take over the function of a permanently damaged organ.

DRIVING FACTORS

"Increasing incidence of cancer is driving the market growth"

One of the key driving factors in the global stem cell exosome therapeutic market growth is the increasing prevalence of cancer globally. As the expansion of cancer continues to rise, there is a growing demand for innovative therapies to address them. This surge in demand has put exosome based technologies at the forefront of cancer research and treatment. The concept of liquid biopsy, which involves analysis of biomarkers in bodily fluids such as blood, urine or saliva is gaining eminence in cancer diagnostic. Exosomes are stable carriers of molecular information and are also ideal candidates for liquid biopsy approaches. Researchers are exploring the use of exosomal biomarkers for monitoring disease progression, treatment response and detecting minimal residual disease.

"Growing R&D Activities Associated with Exosome Research are boosting the market"

Another driving factor in the global stem cell exosome therapeutic market is the growing R&D activities. The growing number of articles associated with exosomal research is enhancing R&D activities in the field.. Along with the substantial rise in article publication, the huge range of companies widely engaged in research is also increasing. Hence, an increase in funding for R&D is set to boost industrial growth positively.

RESTRAINING FACTORS

"Contamination Associated with Exosomes Impede Market Growth"

One of the key restraining factors in the global stem cell exosome therapeutic market is the contamination associated with exosomes. If the exosomes are not properly extracted and sterilized, they can contain intracellular or extracellular genetic material. This genetic material can be very harmful. This can send wrong signals to cells, potentially causing abnormal development of cells at the target site or other areas in the body. Thus, this factor leads to market hindrance.

STEM CELL EXOSOME THERAPEUTIC MARKET REGIONAL INSIGHTS

• 

• to learn more about this report

"North America Region Dominates the Market due to Presence of Advanced Biotechnology Sector"

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America is a predominant player in the global stem cell exosome therapeutics market share due to presence of its advanced biotechnology sector, significant investments in medical research, and a strong focus on innovative therapeutic solutions. Key Trend factors contributing to this market dominance include robust healthcare infrastructure, substantial government and private funding in biotech and pharmaceutical research, and the presence of leading universities and research institutions that drive advancements in exosome Isolation science. Market dynamics in North America are also influenced by an aggressive approach toward the development of novel therapeutics, including those for cancer and degenerative diseases, where exosome therapy shows promise. Also, this region's firm regulatory environment ensures high standards in research and development, further bosting the market's growth.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Groundbreaking Research and Strategic Collaborations"

The stem cell exosome therapeutic market is significantly influenced by key industry players that play a pivotal role in driving market dynamics. In the rapidly emerging exosome therapeutics market, a blend of innovative biotech firms is shaping the industry’s trajectory with groundbreaking research and strategic collaborations. Codiak BioSciences and Evox Therapeutics are at the forefront, recognized for their pioneering work in exosome engineering and drug delivery systems. Their strategic positioning emphasizes advanced therapies for a range of diseases, setting a benchmark in stem cell  exosome therapeutics market. Capricor Therapeutics and ReNeuron Group have carved out significant niches with their focus on regenerative medicine and neurodegenerative diseases, respectively. Their contributions are vital in exploring the therapeutic potential of exosomes in complex medical conditions. These key players collectively drive the exosome therapeutics market through a combination of pioneering research, strategic partnerships, and a focus on developing novel therapeutics and diagnostic tools based on exosome technology, paving the way for next-generation medical treatments.

List of Market Players Profiled

• Aegle Therapeutics ( U.S.)
• Brexogen ( South Korea )
• Cell Care Therapeutics ( U.S.)
• CHA Biotech ( South Korea )
• ExoCoBio ( South Korea )
• Exopharm ( Australia )
• OmniSpiant ( Ireland )
• BrainStorm Cell Therapeutics ( U.S.)
• Novadip Biosciences ( Belgium )
• Unicyte AG (Switzerland)
• Exogenus Therapeutics ( Portugal )

INDUSTRIAL DEVELOPMENT

August 2023:  Evox Therapeutics announced a research collaboration with the Icahn School of Medicine to develop exosome encapsulated AAV vectors as a novel gene delivery technology to improve the treatments for heart disease. 

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.